A retrospective study by Fengqing Cai et al. demonstrated a reduction in the number of CP-positive patients during the pandemic [19], and our research suggested that there was no remarkable difference in the infection rate of CP between 2019 and 2023. The gene discussed is CP; the disease is infection.